Last reviewed · How we verify
NCT06172517
Plantar Fasciitis Management on Postural Control
NA trial testing Orthosis intervention in Rehabilitation in 24 participants. Completed in 28 December 2024.
28 December 2024
Quick facts
| Lead sponsor | Université du Québec à Chicoutimi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 8 January 2024 |
| Primary completion | 28 December 2024 |
| Estimated completion | 28 December 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Orthosis intervention
Conditions studied
- Rehabilitation — all drugs for Rehabilitation →
- Aging Problems — all drugs for Aging Problems →
- Foot Diseases — all drugs for Foot Diseases →
- Mobility Limitation — all drugs for Mobility Limitation →
Sponsor
Université du Québec à Chicoutimi
Who can join
Adults 20 to 65, any sex, with Rehabilitation or Aging Problems. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Foot pain is common in the general population. Plantar fasciopathy may affect 7% of the population at some time in their lives, but the incidence increases with age. This plantar problem is characterized by severe pain under the foot (at plantar level), which can be very incapacitating and disabling. This can lead to absenteeism from work, particularly for employees working in a standing posture. Various therapeutic avenues can be used to reduce pain and improve functionality, such as physiotherapy, infiltrations and surgery. In this research project, the propose the use of a conservative approach through the use of foot orthoses, which appears to be effective in reducing pain. The aim of the study is thus to better understand the effect of foot orthoses on postural balance and walking in workers with plantar fasciopathy. Participants will be assessed at baseline and eight weeks later to observe measured changes and clinical improvements following orthotic wear. Balance and gait pattern will be assessed using technological tools that have been validated in this respect. Participants will also be asked about their pain intensity. The hypothesis is that wearing the orthosis will improve the participants' balance and walking abilities, as well as reduce the level or intensity of their pain. In addition, this study could have an impact on the rate of absenteeism from work from current context of labour shortages.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06172517
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rehabilitation
Currently open trials in the same condition.
- NCT07450274 — Rehabilitation of Upper Limbs After Stroke · NA · recruiting
- NCT07419217 — Professional Impact of Osteoarticular Trauma · recruiting
- NCT07399262 — Music-Augmented Rhythmic Gait Training in Multiple Sclerosis · NA · recruiting
- NCT07333079 — Rehabilitation With Biofeedback for People After Stroke · NA · recruiting
- NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting
Other Université du Québec à Chicoutimi trials
Trials by the same sponsor.
- NCT07002853 — Nature-based Intervention for Chronic Pain in Older People · NA · recruiting
- NCT06452043 — Nature-based Therapy Program for Parkinson's Disease (PARC) · NA · completed
- NCT06175871 — New Clinical Rehabilitation Approach for the Management of Falls Risks · NA · recruiting
- NCT05072288 — A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06172517 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université du Québec à Chicoutimi
- Last refreshed: 23 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06172517.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing